Our Methodology
How we test, how we’re funded, and why it matters.
Community-driven sourcing
The community nominates suppliers and peptides to test. We bulk order directly from the most-requested suppliers — the same way a regular customer would. No vendor-submitted samples. No advance notice to the supplier. No cherry-picked vials.
This is called blind purchasing. It means the supplier has no idea which batch will be tested, so the results reflect what any customer would actually receive.
What we test
Every batch goes through five tests:
HPLC Purity
Measures purity percentage via chromatographic separation. A clean chromatogram with a single dominant peak indicates high purity with minimal impurities.
Identity (Mass Spectrometry)
Confirms the peptide is what it claims to be. Mass spectrometry independently verifies molecular identity. A peptide can show high purity on HPLC while being the wrong compound entirely — mass spec catches that.
Potency / Quantity Verification
Confirms the vial contains the labeled amount. If the label says 10mg, we verify it’s actually close to 10mg — not 7mg or 4mg. A peptide can be pure but severely under-filled. Potency testing catches that gap between what’s claimed and what’s actually in the vial.
Endotoxin
Screens for bacterial contamination (lipopolysaccharides from gram-negative bacteria). Many testing platforms skip this because it’s expensive. We don’t.
Heavy Metals
Tests for lead, mercury, arsenic, and cadmium, which can contaminate peptides during synthesis.
We pull multiple samples from each batch, not just one. A single sample proves a single vial. Multiple samples prove the batch.
Lab standards
All testing is performed at Vanguard Laboratory, an ISO/IEC 17025 accredited lab. ISO 17025 is the international standard for laboratory competence — it means the lab’s methods, equipment, and personnel are independently audited and verified.
We name the lab on every batch page. You can verify their accreditation independently. We don’t use anonymous labs or hide where the testing was done.
How we’re funded
When a batch passes testing, we sell the verified vials. Revenue from those sales funds the next round of testing. When a batch fails, we eat the cost and publish the full results.
That’s the entire business model. The testing funds itself through commerce.
Conflict of interest policy
We do not accept money from the suppliers we test. No payments, no sponsorships, no partnerships, no premium listings, no advertising fees. Zero vendor revenue.
Some testing platforms charge vendors for ratings, premium placements, or testing services — then publish grades for those same vendors. We believe that model has a structural conflict of interest, regardless of good intentions.
Our incentive is simple: we only make money when a batch is genuinely good enough to sell. Failed batches cost us money. The only way this business works is if the testing is honest.
What we publish
Every batch page includes:
- Full chain of custody timeline with timestamps
- Test results for every sample (purity, identity, potency, endotoxin, heavy metals)
- Lab name and accreditation
- Downloadable PDF reports and chromatograms
- Pass/fail determination and reasoning
Failed batches are published on our failures page with the same level of detail as passing batches. We don’t hide bad results, remove them later, or quietly move on.
Per-vial verification
Every vial sold gets a unique QR code. Scan it and you see which batch it belongs to, the full test results, the chain of custody timeline, and the lab reports. No trust required — just data.